Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Voyager Therapeutics

Explore full profile

Gene therapies for neurological diseases crossing blood-brain barrier.

Cambridge, United StatesFounded 2014Biotech & Life Sciences
Valuation $76M Market cap · Aug/2026
Revenue $39M Latest reported FY

At a glance

Founded
2014
Headquarters
Cambridge, United States
Listing
IPO 2015
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Investors

11 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A1 investor entered at this stage

Series B and later10 investors entered at this stage

Employees mapped 161 incl. 5 AI specialists
Founders Hidden — book a demo/100 quality score
Key operators 8 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States99.3%
🇲🇽 Mexico0.7%
2 countries shown
Web traffic by country
11K monthly visits
across markets
🇺🇸 United States78.2%
🇬🇧 United Kingdom7.3%
🇮🇳 India6.4%
🇦🇺 Australia5.5%
Top 4 markets shown

Patents

Estimated portfolio value
$42M

80 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Voyager Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Voyager Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.